Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

NeuBase Therapeutics, Inc. NBSE

Set alert

Price alert · NBSE

All alert types
0.38 +0.38 —

Day range unavailable

52-week range unavailable

Open
—
Prev close
0.00
Mkt cap
1.42M
Vol
0
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
—
High
—
Forward P/E
-0.03
Beta
0.94
Short ratio
0.24
Inst. own
11.87%
Dividend
0.00
Ex-div date
Earnings
Dec 26, 2024
50-d avg
0.472587
200-d avg
0.722122
1y target
0.00

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for NBSE has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-10.54 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -0.4×
FY 2013: -8.9×FY 2014: -5.9×FY 2015: -5.2×FY 2016: -3.4×FY 2017: -1.4×FY 2018: -0.8×FY 2019: -1.5×FY 2020: -8.6×FY 2021: -3.8×FY 2022: -0.4×
FY 2013 5y median -1.5× FY 2022
P/S 0.0×
FY 2013: 0.0×FY 2014: 0.0×FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×
FY 2013 5y median 0.0× FY 2022
P/B 0.6×
FY 2013: 9.6×FY 2014: 2.0×FY 2015: 1.8×FY 2016: 3.6×FY 2017: 1.4×FY 2018: 1.0×FY 2019: 4.1×FY 2020: 4.8×FY 2021: 1.8×FY 2022: 0.6×
FY 2013 5y median 1.8× FY 2022
P/FCF -0.4×
FY 2013: -18.8×FY 2014: -6.0×FY 2015: -7.2×FY 2016: -5.5×FY 2017: -1.7×FY 2018: -1.1×FY 2019: -12.1×FY 2020: -13.0×FY 2021: -4.9×FY 2022: -0.4×
FY 2013 5y median -4.9× FY 2022
EV/EBITDA 0.1×
FY 2013: -10.0×FY 2014: -4.7×FY 2015: -3.0×FY 2016: -3.2×FY 2017: -0.9×FY 2018: -2.3×FY 2019: -1.2×FY 2020: -6.8×FY 2021: -2.1×FY 2022: 0.1×
FY 2013 5y median -2.1× FY 2022
EV/Sales 0.0×
FY 2013: 0.0×FY 2014: 0.0×FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×
FY 2013 5y median 0.0× FY 2022
FCF Yield -229.8%
FY 2013: -5.3%FY 2014: -16.6%FY 2015: -13.9%FY 2016: -18.0%FY 2017: -59.9%FY 2018: -87.6%FY 2019: -8.2%FY 2020: -7.7%FY 2021: -20.6%FY 2022: -229.8%
FY 2013 5y median -20.6% FY 2022

Profitability

Gross Margin 0.0%
FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2013 5y median 0.0% FY 2022
Operating Margin 0.0%
FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2013 5y median 0.0% FY 2022
Net Margin 0.0%
FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2013 5y median 0.0% FY 2022
ROE -147.6%
FY 2013: -107.4%FY 2014: -34.1%FY 2015: -35.8%FY 2016: -103.2%FY 2017: -104.2%FY 2018: -121.4%FY 2019: -270.1%FY 2020: -55.2%FY 2021: -47.5%FY 2022: -147.6%
FY 2013 5y median -121.4% FY 2022
ROIC -114.2%
FY 2013: -87.5%FY 2014: -34.0%FY 2015: -41.9%FY 2016: -98.2%FY 2017: -102.5%FY 2018: -126.7%FY 2019: -259.4%FY 2020: -53.9%FY 2021: -43.8%FY 2022: -114.2%
FY 2013 5y median -114.2% FY 2022
ROA -104.7%
FY 2013: -98.4%FY 2014: -28.5%FY 2015: -32.8%FY 2016: -87.5%FY 2017: -85.3%FY 2018: -113.9%FY 2019: -216.2%FY 2020: -50.1%FY 2021: -40.0%FY 2022: -104.7%
FY 2013 5y median -104.7% FY 2022

Growth (YoY)

Revenue 0.0%
FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2013 FY 2022
Operating Income -25.4%
FY 2013: -40.6%FY 2014: -97.4%FY 2015: -95.2%FY 2016: -38.1%FY 2017: 3.3%FY 2018: 41.5%FY 2019: -89.4%FY 2020: 35.2%FY 2021: -55.6%FY 2022: -25.4%
FY 2013 FY 2022
EPS (diluted) -12.1%
FY 2013: -195.8%FY 2014: -36.5%FY 2015: -29.7%FY 2016: -53.6%FY 2017: 35.3%FY 2018: 56.0%FY 2019: 30.0%FY 2020: 73.1%FY 2021: -6.8%FY 2022: -12.1%
FY 2013 FY 2022
Free Cash Flow -45.2%
FY 2013: -50.5%FY 2014: -229.5%FY 2015: -22.8%FY 2016: -47.1%FY 2017: -20.6%FY 2018: 50.8%FY 2019: 64.2%FY 2020: -236.3%FY 2021: -77.8%FY 2022: -45.2%
FY 2013 FY 2022

Financial Health

Current Ratio 5.9×
FY 2013: 10.8×FY 2014: 2.5×FY 2015: 7.5×FY 2016: 3.0×FY 2017: 2.6×FY 2018: 5.5×FY 2019: 4.4×FY 2020: 10.4×FY 2021: 13.1×FY 2022: 5.9×
FY 2013 5y median 5.9× FY 2022
Quick Ratio 5.9×
FY 2013: 10.8×FY 2014: 2.5×FY 2015: 7.5×FY 2016: 3.0×FY 2017: 2.6×FY 2018: 5.5×FY 2019: 4.4×FY 2020: 10.4×FY 2021: 13.1×FY 2022: 5.9×
FY 2013 5y median 5.9× FY 2022
Debt / Equity 0.3×
FY 2013: 0.0×FY 2014: 0.0×FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.1×FY 2022: 0.3×
FY 2013 5y median 0.0× FY 2022
Net Debt / EBITDA 0.5×
FY 2013: 1.1×FY 2014: 1.5×FY 2015: 1.7×FY 2016: 0.5×FY 2017: 0.6×FY 2018: 1.2×FY 2019: 0.4×FY 2020: 1.9×FY 2021: 1.9×FY 2022: 0.5×
FY 2013 5y median 1.2× FY 2022
Interest Coverage -1386×
FY 2013: -985×FY 2014: -1636×FY 2015: -2979×FY 2016: -21.0×FY 2017: -769×FY 2018: 0.0×FY 2019: -204×FY 2020: -2221×FY 2021: -822×FY 2022: -1386×
FY 2013 5y median -822× FY 2022

Dividends

Dividend Yield 0.0%
FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2013 5y median 0.0% FY 2022
Payout Ratio 0.0%
FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2013 5y median 0.0% FY 2022

Annual · latest fiscal year ends 2022-09-30